Mivacron (Mivacurium)

Mivacurium, the active ingredient in Mivacron, is a non-depolarizing neuromuscular blocker presented as a sterile injection for intravenous use. It facilitates tracheal intubation, provides muscle relaxation during surgery, and serves as an adjunct to general anesthesia.

GNH USA supplies Mivacron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mivacron is a non‑depolarizing neuromuscular blocker used in peri‑operative care to achieve rapid and controlled muscle relaxation.

- Facilitation of tracheal intubation: provides quick onset paralysis to allow safe airway management. - Muscle relaxation during surgery: maintains skeletal muscle paralysis throughout operative procedures. - Adjunct to general anesthesia: enhances anesthetic depth and prevents patient movement.

Mivacron may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Transient histamine release: mild flushing or rash. - Bronchospasm: wheezing, especially in patients with reactive airway disease. - Hypotension: temporary drop in blood pressure. - Nausea: occasional feeling of queasiness. - Headache: mild, self‑limiting.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate intervention. - Prolonged neuromuscular blockade: extended paralysis beyond the intended period. - Cardiac arrhythmias: irregular heart rhythm, potentially life‑threatening. - Severe hypotension: marked blood pressure fall with shock risk. - Respiratory depression: inadequate ventilation requiring support.

When using Mivacron, careful monitoring and patient assessment are essential.

- Assess neuromuscular function: monitor train‑of‑four response throughout administration. - Avoid in patients with known hypersensitivity to mivacurium or related compounds. - Use caution in hepatic or renal impairment: altered drug clearance may prolong effects. - Be prepared to manage histamine‑mediated reactions: have antihistamines and emergency equipment ready. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mivacron can interact with several agents that influence neuromuscular transmission or cardiovascular stability.

Major Interactions (Avoid): - Aminoglycoside antibiotics: potentiate neuromuscular blockade, increasing risk of prolonged paralysis. - Lithium: may enhance the duration and intensity of muscle relaxation.

Moderate Interactions (Monitor Closely): - Inhalational anesthetics (e.g., sevoflurane, desflurane): additive muscle‑relaxant effects. - Magnesium sulfate: enhances blockade, requiring dose adjustment. - Beta‑adrenergic blockers: may affect hemodynamic response during administration.